Cargando…

Reason for peripheral blood natural killer cell depletion in severe COVID-19 patients

Detalles Bibliográficos
Autor principal:	Razizadeh, Mohammad Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462635/ https://www.ncbi.nlm.nih.gov/pubmed/36085401 http://dx.doi.org/10.1007/s11845-022-03154-z

Ejemplares similares

Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19)
por: Garcia-Muñoz, Ricardo, et al.
Publicado: (2021)

Natural killer cells in COVID-19: from infection, to vaccination and therapy
por: Zafarani, Alireza, et al.
Publicado: (2023)

Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma
por: He, L, et al.
Publicado: (2016)

Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
por: Razizadeh, Mohammad Hossein, et al.
Publicado: (2023)

Primary Natural Killer/T-Cell Lymphoma of the Ribs
por: Kim, Kyoung Min, et al.
Publicado: (2023)

Suitability of EDTA-anticoagulated Blood for Natural Killer Cell Activity Testing Using Flow Cytometry
por: Ryu, Jeayeon, et al.
Publicado: (2023)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Peripheral Blood Smear Findings in COVID-19
por: Ahnach, Maryame, et al.
Publicado: (2020)

Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells
por: Haque Chowdhury, Helena, et al.
Publicado: (2021)

Peripheral Blood Smears in COVID-19: A Comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Peripheral Blood Smears in COVID-19: A Response
por: Ahnach, Maryame
Publicado: (2021)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Myeloma natural killer cells are exhausted and have impaired regulation of activation
por: D’Souza, Criselle, et al.
Publicado: (2021)

Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients
por: Bao, Changqian, et al.
Publicado: (2021)

Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case
por: Sarıbacak Can, Esra, et al.
Publicado: (2016)

Natural killer cell-mediated immune deficiency or compromise in patients with portopulmonary hypertension
por: Chen, Huisong, et al.
Publicado: (2014)

Annular Erythematous Patches as the Presenting Sign of Extranodal Natural Killer/T-Cell Lymphoma
por: Baykal, Can, et al.
Publicado: (2016)

Human natural killer cells in major histocompatibility complex class I deficiency
por: Patil, Neha D., et al.
Publicado: (2021)

A four-stage model for murine natural killer cell development in vivo
por: Ma, Shoubao, et al.
Publicado: (2022)

COVID-19: scientific reasoning, pragmatism and emotional bias
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Reasons for COVID-19 vaccination hesitancy in hemodialysis patients
por: Bhandari, Sunil
Publicado: (2021)

The Reasons for Excess Mortality during the COVID-19 Pandemic
por: Leffler, Christopher T., et al.
Publicado: (2022)

The unique COVID-19 presentation of patients with B cell depletion: author's response
por: Belkin, Ana, et al.
Publicado: (2023)

Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis
por: Cai, Yi, et al.
Publicado: (2020)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Involving Skin Masquerading as Eczema
por: Kim, Ji Seok, et al.
Publicado: (2016)

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2020)

COVID-19 vaccine booster in healthcare workers - reasons for refusing
por: Cunha, R., et al.
Publicado: (2022)

Underlying reasons for the decline in physical activity during COVID-19
por: Zhang, Yang-Fen, et al.
Publicado: (2022)

Regulation of sepsis-induced IFNγ upon natural killer cell or natural killer T cell depletion in vivo
por: Christaki, E, et al.
Publicado: (2012)

Reasons for discarding blood from blood bank of government medical college, Aurangabad
por: Thakare, Meenal M., et al.
Publicado: (2011)

Enhancing the use of natural killer cells as a promising therapy against monkeypox: Mechanisms and implications
por: Mehta, Kahan, et al.
Publicado: (2023)

Peripheral Blood Invariant Natural Killer T Cells of Pig-Tailed Macaques
por: Li, Xiangming, et al.
Publicado: (2012)

Prognostic value of peripheral blood natural killer cells in colorectal cancer
por: Tang, Yan-ping, et al.
Publicado: (2020)

Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection
por: Pathak, Subodh Kumar, et al.
Publicado: (2020)

Intramuscular deposit of calcium is a potential reason for hypocalcaemia in COVID-19
por: Kalbhenn, Johannes, et al.
Publicado: (2021)

Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.
por: Múñez-Rubio, Elena, et al.
Publicado: (2023)

The First Korean Case of Epstein-Barr Virus-positive Natural Killer/T-cell Lymphoma That Progressed From Severe Mosquito Bite Allergy, With Coexistence of Hemophagocytic Lymphohistiocytosis
por: Lee, Seunghoo, et al.
Publicado: (2020)

First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea
por: Lee, Jiwon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i5t9j53hnd8of5lgt4aebcdjnh